Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
---|
10/11/1995 | EP0675955A1 Molecular flashlight |
10/11/1995 | EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen |
10/10/1995 | US5457195 Sapphyrin derivatives and conjugates |
10/10/1995 | US5457183 Radiosensitizers |
10/10/1995 | US5456901 Administering liposome having encapsulated contrast enhancing agent, scanning patient using ultrasonic imaging |
10/10/1995 | US5456663 Drugs and methods for treating diseases |
10/05/1995 | WO1995026359A1 Macromolecular structures for boron neutron-capture therapy |
10/05/1995 | WO1995026354A1 New iodized boron compounds useful as x ray contrasting agents, and pharmaceutical compositions containing them |
10/05/1995 | WO1995026353A1 New iodized boron compounds useful as x-ray contrasting agents, and pharmaceutical compositions containing them |
10/05/1995 | CA2135158A1 Macromolecular structures for boron neutron-capture therapy |
10/03/1995 | US5455022 Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy |
09/21/1995 | WO1995024930A1 Use of green porphyrins in ocular diagnosis and therapy |
09/21/1995 | WO1995024888A1 Methods for phototherapeutic treatment of proliferative skin diseases |
09/21/1995 | WO1995020960A3 Dna damaging agents in combination with tyrosine kinase inhibitors |
09/21/1995 | CA2185440A1 Methods for phototherapeutic treatment of proliferative skin diseases |
09/20/1995 | EP0671911A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
09/19/1995 | US5451599 Complex salts of hematoporphyrin and of its derivatives, their synthesis, and therapeutic agent |
09/19/1995 | US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes |
09/14/1995 | WO1995024184A1 Gas filled microspheres as magnetic resonance imaging contrast agents |
09/13/1995 | EP0529002A4 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
08/30/1995 | EP0668772A1 Specific immune system modulation |
08/30/1995 | EP0515404B1 Photodynamic activity of sapphyrins |
08/29/1995 | US5446157 Boron difluoride compounds useful in photodynamic therapy and production of laser light |
08/29/1995 | US5445608 Method and apparatus for providing light-activated therapy |
08/22/1995 | US5443813 A biocompatible apoferritin the blood protein ferritin which has iron content removed to fill with radioactive uranium; drug delivery |
08/17/1995 | WO1995021845A1 Texaphyrin metal complexes having improved functionalization |
08/17/1995 | CA2182960A1 Texaphyrin metal complexes having improved functionalization |
08/16/1995 | EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
08/15/1995 | CA1336739C Diphosphonate-derivatized macromolecules |
08/10/1995 | WO1995020961A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
08/10/1995 | WO1995020960A2 Dna damaging agents in combination with tyrosine kinase inhibitors |
08/08/1995 | US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production |
08/03/1995 | WO1995020390A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
08/03/1995 | CA2179715A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
08/01/1995 | US5438071 Stable porfimer sodium compositions and methods for their manufacture |
07/27/1995 | WO1995019705A1 Intravenous administration of psoralen |
07/26/1995 | EP0663838A1 Stable, highly concentrated formulations of fluorescein derivatives |
07/13/1995 | WO1995018629A1 Method for treatment and prevention of disease in animals |
07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |
07/11/1995 | US5432171 Water soluble texaphyrin metal complexes for viral deactivation |
07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
07/05/1995 | EP0660936A1 Up-converting reporters for biological and other assays using laser excitation techniques |
07/05/1995 | EP0660714A1 Novel liposomal drug delivery systems |
07/05/1995 | EP0660712A1 Transcutaneous in vivo activation of photosensitive agents in blood |
07/05/1995 | EP0660687A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
07/04/1995 | US5430051 Photodynamic diagnosis and therapy of rheumatic diseases |
07/04/1995 | US5429634 Biogenic implant for drug delivery and method |
06/28/1995 | EP0659407A1 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
06/27/1995 | US5428163 Prodrugs for selective drug delivery |
06/27/1995 | US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging |
06/14/1995 | EP0656773A1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions. |
06/13/1995 | US5424419 Contrast medium for magnetic resonace imaging, exothermic medium for hyperthermia; very stable |
06/08/1995 | WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters |
06/08/1995 | WO1995015118A1 Gas microspheres for topical and subcutaneous application |
06/08/1995 | CA2617836A1 Nucleosides and oligonucleotides containing boron clusters |
06/08/1995 | CA2177713A1 Gas microspheres for topical and subcutaneous application |
06/07/1995 | EP0656037A1 Metal-mediated cross-coupling with ring-metalated porphyrins |
06/06/1995 | US5422093 Administering to produce protoporphyrin IX which accumulates in rapidly growing cells and fluoresces after exposure to light; anticarcinogenic and -tumor agents; urogenital disorders |
05/31/1995 | EP0654993A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
05/30/1995 | US5419760 Medicament dispensing stent for prevention of restenosis of a blood vessel |
05/26/1995 | WO1995013809A1 Use of phorbine ring derived photosensitizer compounds for the decontamination of parasite and/or virus-infected blood |
05/24/1995 | EP0653911A1 Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
05/23/1995 | US5418130 Phosphonium or ammonium halo-psoralen |
05/18/1995 | WO1995012973A1 Device and method for photoactivation |
05/04/1995 | WO1995011703A1 Nitrophenyl derivatives that can be activated by light |
05/02/1995 | US5411730 Magnetic microparticles |
04/26/1995 | EP0649523A1 Bioassay for the screening of ion channel active molecules |
04/26/1995 | EP0436642B1 Pre-activated therapeutic agents derived from photoactive compounds |
04/25/1995 | US5409900 Porphycene compounds for photodynamic therapy |
04/20/1995 | WO1995010522A1 Phosphorescent compounds for imaging tissue oxygen |
04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
04/20/1995 | WO1995010267A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
04/20/1995 | CA2173738A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
04/19/1995 | EP0648275A1 Method for the epigenetic regulation of protein biosynthesis by scale resonance |
04/19/1995 | EP0648205A1 Peptidyl derivatives as metalloproteinase inhibitors |
04/19/1995 | EP0624096A4 Taxol as a radiation sensitizer. |
04/19/1995 | EP0621880A4 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light. |
04/11/1995 | US5405968 Useful as drugs, for producing singlet oxygen, sensitizers in electrophotographic layers and for photopolymerizations and as laser light sensitive dyes in optical recording media |
04/11/1995 | US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use |
04/11/1995 | US5405598 Sensitizing agents for use in boron neutron capture therapy |
04/06/1995 | WO1995008949A1 Use of photodynamic therapy to treat prostatic tissue |
04/06/1995 | WO1995007072A3 Active principles and gas containing microparticles |
04/04/1995 | US5403928 Fluorescent marker components and fluorescent probes |
03/30/1995 | WO1995008551A1 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
03/29/1995 | EP0645048A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
03/28/1995 | CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
03/21/1995 | US5399719 Compounds for the photodecontamination of pathogens in blood |
03/21/1995 | US5399583 Hydro-monobenzoporphyrins |
03/16/1995 | WO1995007077A1 Photochemotherapeutic compositions containing 5-aminolevulinic acid |
03/16/1995 | WO1995007072A2 Active principles and gas containing microparticles |
03/16/1995 | DE4330958A1 Novel microparticles containing active compound, media containing these, their use for the ultrasonically controlled release of active compounds and process for the production thereof |
03/15/1995 | EP0642342A1 Selective cell inactivation in blood |
03/09/1995 | WO1995006688A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use |
03/09/1995 | WO1995006657A1 Interleukin-10 and immunosuppression |
03/09/1995 | CA2170974A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use |
03/08/1995 | EP0641796A1 Wavelength-specific cytotoxic agents |
03/08/1995 | CN1099613A Method and medical agent for diagnosis and/or therapy of arthritis |
03/08/1995 | CN1099612A Destroying or inhibiting growth of unwanted cells or tissues |
03/02/1995 | WO1995005818A1 Photosensitizers |
02/23/1995 | WO1995005214A1 Method and apparatus for providing light-activated therapy |